Clinical Trials Browser

Phase 2 × Completed × HMPL-013 × Clear all

NCT04716634 2025-03-25

Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors

Phase 2 Completed

84 enrolled 17 charts

Other solid neoplasm

Advanced Solid Tumors

NCT05025631 2023-04-28

DOFEMCRC

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT02196688 2020-06-16

Study of Fruquintinib in Patients With Metastatic Colorectal Cancer

Phase 2 Completed

71 enrolled 13 charts

Gastrointestinal

Colorectal Neoplasms

NCT02976116 2019-11-15

A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer

Phase 2 Completed

NSCLC